Stock Exchange & Press Releases 2024

Print Print this release
February 12, 2024

Bittium Expands Its Range of Supported ECG Analysis Software by Collaborating With a Service Partner

Bittium Corporation
Press Release

Bittium Expands Its Range of Supported ECG Analysis Software by Collaborating With a Service Partner

Bittium Corporation, Press Release on February 12, 2024, at 7.00 a.m. (CET+1)

Bittium expands its ECG analysis software offering to an artificial intelligence-based cardiac diagnostic software provided by a new service partner, the Polish Medicalgorithmics S.A. This cooperation enables Bittium to offer its customers an even more comprehensive solution for diagnosing arrhythmias. Cooperation with well-known players in the field is part of Bittium's strategy which was updated at the end of 2023. Following the new strategy, the company focuses on the development of its existing products and continuous improvement of quality, for example, by utilizing partnerships with other companies. The agreement gives Bittium the right to resell Medicalgorithmics' ECG analysis software globally.

Medicalgorithmics is an international company listed on the Warsaw Stock Exchange, and its cloud-based software utilizing proprietary AI algorithms, is designed for the analysis and reporting of ECG arrhythmia diagnostics. The software will be seamlessly integrated with Bittium's Faros ECG measuring devices. The system has already been successfully commercialized in 22 countries, and existing regulatory approvals allow its introduction in over 50 markets.

"Continuous improvement of product quality and development of features is important to us, and through a partner network we are able to offer our customers even more comprehensive solutions. Our Faros ECG measuring devices have an open interface, and through development cooperation with third parties, we aim to improve our customers' user experience, offer options for different types of customer needs, and expand our market," says Laura Kauppinen, the Senior Vice President of Bittium’s Medical Business Segment. "The healthcare technology market is evolving, and the importance of remote monitoring and remote diagnostics in patient care is constantly growing. More and more efforts are being made to prevent diseases and health problems with the help of early diagnostics, and the aim is to send patients home at an even earlier stage to reduce hospital and treatment days,” Kauppinen continues.

"Teaming up with Bittium allows us to enhance efficiency in ECG signal analysis within the market. This entails streamlining ECG technicians' workload and improving ECG report generation. With Medicalgorithmics' software, which has proven its efficiency and effectiveness across 22 markets, we provide an optimal solution for service providers and healthcare professionals," says Jaros?aw Jerzakowski, Chief Operating Officer of Medicalgorithmics.

Further information:

Laura Kauppinen
Senior Vice President, Medical Business Segment, Bittium
Tel. +358 40 344 3507 (group communications)

Main media


In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, and sports medicine. In addition, Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35-year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, and customized solutions based on its product platforms and R&D services. Bittium’s net sales in 2023 were EUR 75.2 million and operating result was EUR -4.3 million. Bittium is listed on the Nasdaq Helsinki Exchange.